Catalyst Pharmaceutical CPRX Total debt
Total debt at other companies
Other financials
Where this comes from
Calculated from Catalyst Pharmaceutical’s reported figures.
Plus components not separately reported this period.
The official record: Catalyst Pharmaceutical’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Catalyst Pharmaceutical's total debt.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Catalyst Pharmaceutical's total debt?
- Catalyst Pharmaceutical (CPRX) reported total debt of $2.68M in Q1 2026.
- How has Catalyst Pharmaceutical's total debt changed year-over-year?
- Catalyst Pharmaceutical's total debt decreased by 13.3% year-over-year, from $3.09M to $2.68M.
- What is the long-term trend for Catalyst Pharmaceutical's total debt?
- Over 5 years (2020 to 2025), Catalyst Pharmaceutical's total debt has grown at a 149.6% compound annual growth rate (CAGR), from $28.77K to $2.79M.
- What does total debt mean?
- Total debt represents the aggregate sum of all interest-bearing financial obligations, including short-term borrowings, the current portion of long-term debt, and long-term debt instruments. It also encompasses capitalized lease liabilities and other debt-like financing arrangements that require fixed repayment schedules. This metric serves as a comprehensive indicator of a company's total financial leverage and its reliance on external capital providers.